Market Introduction
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.
Market Overview and Dynamics
TheMiddle East & Africakidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.The growth of this market is estimated to grow owing to key driving factors such asrising prevalence of diabetes resulting in renal diseases and rising incidences of renal diseases. However, the market is expected experiencing slow growth during the forecast period owing to the constraint of finance and resources in developing countries.
Key Market Segments
Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.
Major Sources and Companies Listed
Some of the major primary and secondary sources forkidney disease market included in the report areSaudi Center for Organ Transplantation (SCOT), Kidney International Reports, and others.
Reasons to buy the report
- To understand the Middle East & Africakidney disease market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for kidney disease market
- Efficiently plan M&A and partnership deals in Middle East & Africakidney disease market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formKidney disease market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East & Africa region
MIDDLE EAST & AFRICAKIDNEY DISEASE MARKET SEGMENTATION
· Diagnosis
o Blood Tests
o Urine Tests
o Imaging Tests
o Others
· Treatment
o Dialysis
o Others
o Drug Class
§ ACE Inhibitors
§ Angiotensin-II Receptor Blockers
§ Diuretics
§ Others
· Hospitals
· Diagnostic Laboratories
· Others
By Country
· Middle East & Africa
o UAE
o Saudi Arabia
o South Africa
Company Profiles
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVieInc
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Sysmex Corporation
- Siemens AG
- Amgen Inc